 |
|
The Fine Structure of an Iridectomy Specimen From a Patient With Latanoprost-Induced Eye Color Change
Arch Ophthalmol. 1999;117:394-396.
Herein we report the morphologic and ultrastructural features of an iridectomy specimen taken from a patient whose brown-green iris darkened while participating in the phase 3 trial of latanoprost in Sweden.
Ian Grierson, PhD;
William R. Lee, MD, FRCPath, FRCOphth, FRSE;
Daniel M. Albert, MD, MS
From the Royal Liverpool University Hospital, Liverpool, England (Dr Grierson); the University of Glasgow, Glasgow, Scotland (Dr Lee); and the University of Wisconsin, Madison (Dr Albert).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
A Study of Histopathological Features of Latanoprost-Treated Irides With or Without Darkening Compared With Non-Latanoprost-Treated Irides
Albert et al.
Arch Ophthalmol 2008;126:626-631.
ABSTRACT
| FULL TEXT
Bimatoprost-Induced Periocular Skin Hyperpigmentation: Histopathological Study
Kapur et al.
Arch Ophthalmol 2005;123:1541-1546.
ABSTRACT
| FULL TEXT
A Study of Iridectomy Histopathologic Features of Latanoprost- and Non-Latanoprost-Treated Patients
Albert et al.
Arch Ophthalmol 2004;122:1680-1685.
ABSTRACT
| FULL TEXT
Fine Structural Evaluation of the Iris After Unilateral Treatment With Latanoprost in Patients Undergoing Bilateral Trabeculectomy (The Mainz II Study)
Pfeiffer et al.
Arch Ophthalmol 2003;121:23-31.
ABSTRACT
| FULL TEXT
Incidence of iris colour change in latanoprost treated eyes
Teus et al.
Br. J. Ophthalmol. 2002;86:1085-1088.
ABSTRACT
| FULL TEXT
Induction of Tyrosinase Gene Transcription in Human Iris Organ Cultures Exposed to Latanoprost
Lindsey et al.
Arch Ophthalmol 2001;119:853-860.
ABSTRACT
| FULL TEXT
Histological Effects in the Iris After 3 Months of Latanoprost Therapy: The Mainz 1 Study
Pfeiffer et al.
Arch Ophthalmol 2001;119:191-196.
ABSTRACT
| FULL TEXT
|
